Honestly, while the uplifting provides 'legitimacy', and even feasibility, in terms of hedge fund investors, it means nothing to the progression of the science.

I'm find with them staying on the OTC as long as Kevetrin proves viable....

nothing else matters beyond the science.
When the science works, and is proven to work... the financial issues seem to nicely fall into place.